A recent ancillary analysis of the LANCE trial examined the feasibility and perioperative outcomes of hyperthermic intraperitoneal chemotherapy in patients undergoing minimally invasive surgery compared...
A recent ancillary analysis of the LANCE trial examined the feasibility and perioperative outcomes of hyperthermic intraperitoneal chemotherapy in patients undergoing minimally invasive surgery compared...
A recent ancillary analysis of the LANCE trial examined the feasibility and perioperative outcomes of hyperthermic intraperitoneal chemotherapy in patients undergoing minimally invasive surgery compared...
A recent ancillary analysis of the LANCE trial examined the feasibility and perioperative outcomes of hyperthermic intraperitoneal chemotherapy in patients undergoing minimally invasive surgery compared...
A retrospective cohort study assessed the impact of delayed postoperative chemotherapy initiation on survival outcomes in patients with endometrial cancer, highlighting a significant association with...
A retrospective cohort study assessed the impact of delayed postoperative chemotherapy initiation on survival outcomes in patients with endometrial cancer, highlighting a significant association with...
A retrospective cohort study assessed the impact of delayed postoperative chemotherapy initiation on survival outcomes in patients with endometrial cancer, highlighting a significant association with...
A retrospective cohort study assessed the impact of delayed postoperative chemotherapy initiation on survival outcomes in patients with endometrial cancer, highlighting a significant association with...
A retrospective cohort study assessed the impact of delayed postoperative chemotherapy initiation on survival outcomes in patients with endometrial cancer, highlighting a significant association with...
A retrospective cohort study assessed the impact of delayed postoperative chemotherapy initiation on survival outcomes in patients with endometrial cancer, highlighting a significant association with...
